Scott Webster Research Group
Information on the research interests, projects, and members of Scott Webster's Research Group.
Professor Scott Webster
Personal Chair of Medicines Discovery
The primary focus of my research is drug discovery. I conduct translational research with a focus on discovering and developing small molecules as drugs for the treatment of conditions such as Alzheimer’s disease, acute pancreatitis, liver fibrosis and multiple sclerosis. This is research is highly collaborative with close involvement of both academic and industrial collaborators across a range of discplines. My research has led to the discovery of a number of potent small molecule inhibitors of target enzymes, with the most advanced compound, UE2343 (XanamemTM), out-licensed and progressing through clinical trials in humans. My group provides expertise in target validation through assay devlopment and in vitro screening to lead optimisation and clinical candidate selection.
For a list of up-to-date publications, please visit:
Research Group Members
|Name (sorted in ascending order)||Role|
Other Group Members
|Pierre Rome||Research Fellow|